These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 8890967)
1. High-dose-rate brachytherapy for poor-prognosis, high-grade glioma: (phase II) preliminary results. Micheletti E; La Face B; Feroldi P; Galelli M; Buttolo L; Stefini R; Giunta F Tumori; 1996; 82(4):339-44. PubMed ID: 8890967 [TBL] [Abstract][Full Text] [Related]
2. High-dose interstitial brachytherapy for glioblastoma multiforme. Micheletti E; Baroncelli G; La Face B; Feroldi P; Galelli M; Giunta F Tumori; 1994 Feb; 80(1):44-9. PubMed ID: 8191598 [TBL] [Abstract][Full Text] [Related]
3. Hypofractionated radiotherapy as palliative treatment in poor prognosis patients with high grade glioma. Thomas R; James N; Guerrero D; Ashley S; Gregor A; Brada M Radiother Oncol; 1994 Nov; 33(2):113-6. PubMed ID: 7535939 [TBL] [Abstract][Full Text] [Related]
4. Results of high dose rate afterloading brachytherapy boost to conventional external beam radiation therapy for initial and locally advanced prostate cancer. Pellizzon AC; Nadalin W; Salvajoli JV; Fogaroli RC; Novaes PE; Maia MA; Ferrigno R Radiother Oncol; 2003 Feb; 66(2):167-72. PubMed ID: 12648788 [TBL] [Abstract][Full Text] [Related]
5. A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer. Mattiucci GC; Autorino R; Tringali A; Perri V; Balducci M; Deodato F; Gambacorta MA; Mantini G; Tagliaferri L; Mutignani M; Morganti AG Brachytherapy; 2015; 14(3):401-4. PubMed ID: 25591935 [TBL] [Abstract][Full Text] [Related]
6. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838 [TBL] [Abstract][Full Text] [Related]
7. Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: the William Beaumont phase II dose-escalating trial. Martinez AA; Kestin LL; Stromberg JS; Gonzalez JA; Wallace M; Gustafson GS; Edmundson GK; Spencer W; Vicini FA Int J Radiat Oncol Biol Phys; 2000 May; 47(2):343-52. PubMed ID: 10802358 [TBL] [Abstract][Full Text] [Related]
8. Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer. Wazer DE; Berle L; Graham R; Chung M; Rothschild J; Graves T; Cady B; Ulin K; Ruthazer R; DiPetrillo TA Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):889-97. PubMed ID: 12095554 [TBL] [Abstract][Full Text] [Related]
9. Radiotherapy with high dose rate brachytherapy boost and concomitant chemotherapy for Stages IIB and III esophageal carcinoma: results of a pilot study. Calais G; Dorval E; Louisot P; Bourlier P; Klein V; Chapet S; Reynaud-Bougnoux A; Huten N; De Calan L; Aget H; Le Floch O Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):769-75. PubMed ID: 9240645 [TBL] [Abstract][Full Text] [Related]
10. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy. Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495 [TBL] [Abstract][Full Text] [Related]
11. Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma--an International Atomic Energy Agency study. Sur RK; Levin CV; Donde B; Sharma V; Miszczyk L; Nag S Int J Radiat Oncol Biol Phys; 2002 May; 53(1):127-33. PubMed ID: 12007950 [TBL] [Abstract][Full Text] [Related]
17. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma. Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654 [TBL] [Abstract][Full Text] [Related]
18. Treatment results of high-dose-rate remote afterloading brachytherapy for cervical cancer and retrospective comparison of two regimens. Wong FC; Tung SY; Leung TW; Sze WK; Wong VY; Lui CM; Yuen KK; O SK Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1254-64. PubMed ID: 12654435 [TBL] [Abstract][Full Text] [Related]
19. Is single fraction 15 Gy the preferred high dose-rate brachytherapy boost dose for prostate cancer? Morton G; Loblaw A; Cheung P; Szumacher E; Chahal M; Danjoux C; Chung HT; Deabreu A; Mamedov A; Zhang L; Sankreacha R; Vigneault E; Springer C Radiother Oncol; 2011 Sep; 100(3):463-7. PubMed ID: 21924511 [TBL] [Abstract][Full Text] [Related]
20. High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications. Ferrigno R; dos Santos Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Gentil AC; Salvajoli JV Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1123-35. PubMed ID: 11483321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]